Based on the strength of the trial’s results, Pfizer says it will ask the FDA for emergency use authorization rather than enroll more people for clinical trials.
(Image credit: Mark Lennihan/AP)
Pfizer says its COVID-19 pill cuts disease’s worst risks by 89%
